Al Charest
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Genetics top 5%
- Glioma Diagnosis and Treatment
Papers in
-
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 3
- Genetics 6
- Glioma Diagnosis and Treatment 6
- Co-authors
- Jaime Acquaviva (2 shared papers)Ricky Ngok‐Shun Wong (1 shared paper)David E. Housman (3 shared papers)Roderick Terry Bronson (5 shared papers)Ralph Weissleder (4 shared papers)Steve Woolfenden (4 shared papers)Haihao Zhu (3 shared papers)Luis F. Parada (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Cancer Research (2 papers)Journal of Extracellular Vesicles (2 papers)iScience (2 papers)Neuro-Oncology (1 paper)
- Partner nations
- United StatesFrancePoland
In The Last Decade
Al Charest
26 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 507
- Genetics 348
- Oncology 435
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 404
Countries citing papers authored by Al Charest
This map shows the geographic impact of Al Charest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Al Charest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Al Charest more than expected).
Fields of papers citing papers by Al Charest
This network shows the impact of papers produced by Al Charest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Al Charest. The network helps show where Al Charest may publish in the future.
Co-authors
The 25 scholars most cited alongside Al Charest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 250 | |
| 2 | 2015 | 230 | |
| 3 | 2022 | 193 | |
| 4 | 2019 | 188 | |
| 5 | 2009 | 187 | |
| 6 | 2008 | 170 | |
| 7 | 2006 | 137 | |
| 8 | 2016 | 87 | |
| 9 | 2011 | 84 | |
| 10 | 2019 | 56 | |
| 11 | 2009 | 54 | |
| 12 | 2018 | 36 | |
| 13 | 2014 | 32 | |
| 14 | 2010 | 31 | |
| 15 | 2024 | 30 | |
| 16 | 2022 | 23 | |
| 17 | 2009 | 19 | |
| 18 | 2023 | 18 | |
| 19 | 2021 | 18 | |
| 20 | 2020 | 14 |
About Al Charest
Al Charest is a scholar working on Cancer Research, Genetics, Molecular Biology, Oncology and Immunology, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (8 papers), Glioma Diagnosis and Treatment (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), MicroRNA in disease regulation (5 papers), RNA Research and Splicing (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Protein Degradation and Inhibitors (2 papers) and 3D Printing in Biomedical Research (2 papers). The work is most often cited by research in Cancer Research (507 citations), Genetics (348 citations), Oncology (435 citations), Molecular Biology (1.1k citations) and Pulmonary and Respiratory Medicine (404 citations). Al Charest has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Jaime Acquaviva, Ricky Ngok‐Shun Wong, David E. Housman, Roderick Terry Bronson, Ralph Weissleder, Steve Woolfenden, Haihao Zhu, Luis F. Parada, Eric C. Holland and Dolores Hambardzumyan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, Journal of Extracellular Vesicles, iScience and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.